Immunofluorescence studies in brain samples from PD and/or Lewy body dementia individuals, along with GD or GBA mutation carriers, have shown the presence of GCase in LBs and LNs in most cases [17], [18], suggesting a gain-of-function mechanism via a direct interaction. The gene discussed is GBA1; the disease is Parkinson disease.